Business Description
Description
QuantumPharm Inc is a quantum physics-based, AI-powered, and robotics-driven, innovative R&D platform. Its business primarily comprises (i) drug discovery solutions providing modular solutions spanning the full spectrum of the drug discovery and research process, and (ii) intelligent automation solutions consisting primarily of solid-state R&D services and automated chemical synthesis services.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 20.64 | |||||
| Equity-to-Asset | 0.92 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -2.3 | |||||
| Beneish M-Score | -3.4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 14.59 | |||||
| 9-Day RSI | 19.06 | |||||
| 14-Day RSI | 22.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 15.68 | |||||
| Quick Ratio | 15.68 | |||||
| Cash Ratio | 15.08 | |||||
| Days Sales Outstanding | 89.74 | |||||
| Days Payable | 31.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 18.93 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.32 | |||||
| Operating Margin % | -404.53 | |||||
| Net Margin % | -1288.66 | |||||
| FCF Margin % | -347.32 | |||||
| ROA % | -59.99 | |||||
| ROIC % | -64.88 | |||||
| ROC (Joel Greenblatt) % | -479.36 | |||||
| ROCE % | -63.31 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 17.92 | |||||
| PB Ratio | 2.51 | |||||
| Price-to-Tangible-Book | 2.51 | |||||
| EV-to-EBIT | -3.03 | |||||
| EV-to-Forward-EBIT | -30.46 | |||||
| EV-to-EBITDA | -3.03 | |||||
| EV-to-Revenue | 38.67 | |||||
| EV-to-Forward-Revenue | 16.97 | |||||
| EV-to-FCF | -19.95 | |||||
| Price-to-Net-Current-Asset-Value | 3.26 | |||||
| Price-to-Net-Cash | 3.4 | |||||
| Earnings Yield (Greenblatt) % | -33 | |||||
| FCF Yield % | -6.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
QuantumPharm Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 213.797 | ||
| EPS (TTM) (HK$) | -2.248 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 22.74 | ||
| 14-Day ATR (HK$) | 0.812691 | ||
| 20-Day SMA (HK$) | 5.2825 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (HK$) | 3.2 - 16.2 | ||
| Shares Outstanding (Mil) | 3,415.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
QuantumPharm Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
QuantumPharm Inc Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
QuantumPharm Inc Frequently Asked Questions
What is QuantumPharm Inc(HKSE:02228)'s stock price today?
The current price of HKSE:02228 is HK$3.26. The 52 week high of HKSE:02228 is HK$16.20 and 52 week low is HK$3.20.
When is next earnings date of QuantumPharm Inc(HKSE:02228)?
The next earnings date of QuantumPharm Inc(HKSE:02228) is .
Does QuantumPharm Inc(HKSE:02228) pay dividends? If so, how much?
QuantumPharm Inc(HKSE:02228) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers